Cochrane's COVID-19 Living Systematic Reviews: A Mixed-Methods Study of Their Conduct, Reporting and Currency
- PMID: 40656451
- PMCID: PMC12245076
- DOI: 10.1002/cesm.70024
Cochrane's COVID-19 Living Systematic Reviews: A Mixed-Methods Study of Their Conduct, Reporting and Currency
Abstract
Background: Living systematic reviews (LSRs) should provide up-to-date evidence for priority questions where the evidence may be uncertain and fast-moving. LSRs featured prominently during COVID-19 and formed part of Cochrane's response to the pandemic. We conducted a mixed-methods study to describe the characteristics of Cochrane's COVID-19 living reviews, determine the currency of the included evidence, and evaluate authors' experiences in conducting and publishing these reviews.
Methods: We identified living reviews of COVID-19 from the Cochrane Database of Systematic Reviews and extracted data on the number of versions published and publication timelines. We assessed the currency of evidence by comparing studies included in the reviews against a comprehensive list of studies maintained for the Australian living guidelines for COVID-19. The qualitative component involved semi-structured interviews with review authors to identify the barriers and enablers to conducting, reporting and publishing living reviews.
Findings: Cochrane published 25 COVID-19 living systematic reviews. Half of these reviews had not been updated when assessed in June 2023 and only four had been updated more than once. A total of 118 studies were included in the living reviews. We estimated that an additional 119 studies were available and potentially relevant for inclusion. Interviews with six authors indicated that publication timelines were reduced by editorial delays, loss of funding, waning commitment, and the burden of screening search results. An inability to communicate the living status of reviews in the Cochrane Library was a common frustration for many authors. Although authors felt the conclusions of their reviews were still current, only one living review communicated its updated status and made new evidence accessible after the review was published.
Conclusions: Maintaining and communicating the currency of Cochrane's COVID-19 living systematic reviews was not feasible for many author teams because of author-side, editorial and platform barriers.
Keywords: COVID‐19; Cochrane; living systematic reviews.
© 2025 The Author(s). Cochrane Evidence Synthesis and Methods published by John Wiley & Sons Ltd on behalf of The Cochrane Collaboration.
Conflict of interest statement
TT and SM developed Cochrane's guidance for living systematic reviews, evaluated Cochrane's pre‐pandemic LSR pilot, and are co‐authors of Cochrane living reviews unrelated to COVID‐19. Both have Cochrane editorial roles – TT is a member of the Cochrane Library Editorial Board and SM is a member of the Cochrane search peer review panel. All authors are associated with the Australian Living Evidence Collaboration.
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2. Cochrane Database Syst Rev. 2012. PMID: 23152285 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Interventions for promoting habitual exercise in people living with and beyond cancer.Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3. Cochrane Database Syst Rev. 2018. PMID: 30229557 Free PMC article.
References
-
- Hoffmann F., Allers K., Rombey T., et al., “Nearly 80 Systematic Reviews Were Published Each Day: Observational Study on Trends in Epidemiology and Reporting Over the Years 2000–2019,” Journal of Clinical Epidemiology 138 (2021): 1–11. - PubMed
-
- Shojania K. G., Sampson M., Ansari M. T., Ji J., Doucette S., and Moher D., “How Quickly Do Systematic Reviews go Out of Date? A Survival Analysis,” Annals of Internal Medicine 147, no. 4 (2007): 224–233. - PubMed
-
- Elliott J. H., Synnot A., Turner T., et al., “Living Systematic Review: 1. Introduction‐the Why, What, When, and How,” Journal of Clinical Epidemiology 91 (2017): 23–30. - PubMed
-
- Living systematic reviews Cochrane Community: Cochrane Community; 2023 [Available from: https://community.cochrane.org/review-production/production-resources/li....
LinkOut - more resources
Full Text Sources